July 2 (Reuters) - Cartesian Therapeutics Inc :
* CARTESIAN THERAPEUTICS ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 2B TRIAL OF DESCARTES-08 IN PATIENTS WITH MYASTHENIA GRAVIS
* CARTESIAN THERAPEUTICS INC - TRIAL MET PRIMARY ENDPOINT WITH STATISTICAL SIGNIFICANCE
* CARTESIAN THERAPEUTICS INC - SAFETY PROFILE CONTINUES TO SUPPORT OUTPATIENT ADMINISTRATION
* CARTESIAN THERAPEUTICS INC - COMPANY EXPECTS TO HOLD END-OF-PHASE 2 MEETING WITH FDA BY YEAR-END
* CARTESIAN THERAPEUTICS INC - ALSO ANNOUNCED POSITIVE UPDATED RESULTS FROM TWO PATIENTS ENROLLED IN PHASE 2A OPEN-LABEL PORTION OF TRIAL
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Comments